Why Choose miRoncol? - miRoncol Health

Meaningful insight, Real-time cancer risk awareness

When it comes to cancer, timing matters. Standard screening programs are important, but they only cover a few cancers and apply to limited age or risk groups. The miRoncol Real-time Multi-Cancer Early Risk Assessment adds another layer of prevention by detecting molecular signals across multiple solid tumours all from a simple blood test.

Why People Choose miRoncol

Peace of mind – meaningful insight into what’s happening in your body today
High sensitivity for early-stage detection — accurately identifies signals from common solid tumours at their earliest stages.
Breadth of coverage – signals linked to most common cancers that affect Canadians
Supports physician conversations – results designed to complement, not replace, clinical care
Accessible and preventive – non-invasive, blood-based, and suitable for regular health checkups

See Who It’s For

A New Tool in Prevention

Covers more than a dozen common solid tumours — including lung, colorectal, prostate, pancreatic, gastric, ovarian, liver, kidney, cervical, thyroid, bladder, and others.
Built on studies from 11,000+ human data, with specificity above 99% and sensitivity about 90% for many cancers.
AI-enhanced analysis recognizes shared cancer signals and predicts likely tissue of origin when positive (Tissue of Origin (TOO) prediction is planned for introduction in a future phase of the miRoncol test).
Proven scientific foundation, with results published in Cancers (2022) and Scientific Reports (2024).

Explore Scientific Studies And Evidence

Trusted by Professionals

miRoncol works in collaboration with:

Family doctors and integrative medicine practitioners
Executive health, longevity, and wellness clinics
Naturopathic practitioners
Health coaches and wellness professionals
Employers offering top notch employee benefits

Healthcare providers trust miRoncol because it is built on strong studies, ethical use, and complements physician-led decision-making.

Learn About Partner Programs

Meaningful to take actions, Not a life time risk

The miRoncol test doesn’t tell you what might happen in your life time. Instead, it provides a real-time molecular snapshot so you and your physician can discuss whether earlier follow-up is appropriate.

Learn What Real-Time Risk Assessment Means

Next Step

miRoncol is here to help you act earlier, with confidence and clarity. Adding our test to your preventive plan means investing in your health — today and for the future.

Join the Waiting List